Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

403
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
403
Drug Dependence01:17

Drug Dependence

1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

982
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
982
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

253
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
253
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Roles of Prostaglandins PGD2, PGJ2, and PGE2 in the Pathogenesis of Systemic Lupus Erythematosus.

International journal of molecular sciences·2026
Same author

Double humanised lupus mouse model with human immune system and faecal microbiota from patients with SLE.

Lupus science & medicine·2026
Same author

Discovery of Novel Probiotic Species to Improve Infant Health.

bioRxiv : the preprint server for biology·2025
Same author

The pH-Dependent Specificity of Cathepsin S and Its Implications for Inflammatory Communications and Disease.

Biochemistry·2025
Same author

Safety and Toxicological Evaluation of Subunit Keyhole Limpet Hemocyanin-Loaded Lipid-PLGA Hybrid Nanoparticles (sKLH-hNPs) as a Nanocarrier for an Opioid Use Disorder Vaccine.

International journal of toxicology·2025
Same author

Conjugation of Multiple Proteins Onto the Surface of PLGA/Lipid Hybrid Nanoparticles.

Journal of biomedical materials research. Part A·2024

Related Experiment Video

Updated: Jan 16, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.6K

Precision Adjuvant Strategies in Vaccine Development for Substance Use Disorders: Variability and Mechanistic

Yuanzhi Bian1, Qiaoqiao Ci1, Xin M Luo2

  • 1Department of Biological Systems Engineering, College of Engineering & College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA 24061, USA.

Pharmaceutics
|September 27, 2025
PubMed
Summary

Developing effective vaccines for substance use disorders (SUDs) requires careful adjuvant selection. This review highlights that no single adjuvant works best for all drugs, emphasizing tailored strategies for improved vaccine efficacy.

Keywords:
aluminum saltcytokine modulatoremulsion adjuvantnanoparticle vaccineopioid vaccineprecision vaccinologyprotein-based adjuvantsubstance use disordertoll-like receptor agonistvaccine adjuvant

More Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.3K
Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

2.9K

Related Experiment Videos

Last Updated: Jan 16, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.6K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.3K
Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

2.9K

Area of Science:

  • Immunology
  • Vaccinology
  • Pharmacology

Background:

  • Substance use disorders (SUDs) present a significant global health burden with limited effective treatments.
  • Vaccine development for SUDs faces challenges due to the poor immunogenicity of small-molecule drugs (haptens).
  • Adjuvants are crucial for enhancing immune responses and improving the efficacy of SUD vaccines.

Purpose of the Study:

  • To review and synthesize research on adjuvants for SUD vaccines.
  • To guide rational adjuvant design by examining different adjuvant classes and their properties.
  • To establish principles for developing next-generation SUD vaccines.

Main Methods:

  • Comprehensive review of preclinical and clinical research on adjuvants for SUD vaccines over two decades.
  • Examination of five major adjuvant classes: aluminum-salt, emulsion, toll-like receptor (TLR) agonists, protein immunopotentiators, and cytokine modulators.
  • Comparative analysis of adjuvant performance across different drug classes (nicotine, stimulants, opioids) and delivery vehicles.

Main Results:

  • Adjuvant efficacy varies significantly based on the specific drug and the carrier molecule used.
  • Toll-like receptor (TLR) agonist pairs showed superior performance in a nicotine nanovaccine compared to oxycodone vaccines.
  • An oil-in-water emulsion adjuvant demonstrated differential efficacy depending on the antigen type.

Conclusions:

  • No single adjuvant is universally optimal for all SUD vaccines.
  • Drug pharmacology and adjuvant-carrier compatibility are critical factors influencing vaccine outcomes.
  • Tailored, precision vaccinology approaches combining complementary adjuvants are essential for advancing SUD vaccine development.